S&P 500   4,538.43
DOW   34,580.08
QQQ   383.13
S&P 500   4,538.43
DOW   34,580.08
QQQ   383.13
S&P 500   4,538.43
DOW   34,580.08
QQQ   383.13
S&P 500   4,538.43
DOW   34,580.08
QQQ   383.13
NASDAQ:CLOV

Clover Health Investments Stock Forecast, Price & News

$4.30
-0.20 (-4.44%)
(As of 12/3/2021 04:00 PM ET)
Add
Compare
Today's Range
$4.15
$4.55
50-Day Range
$4.30
$8.12
52-Week Range
$4.15
$28.85
Volume
21.36 million shs
Average Volume
22.49 million shs
Market Capitalization
$1.81 billion
P/E Ratio
N/A
Dividend Yield
N/A
Beta
1.52
30 days | 90 days | 365 days | Advanced Chart
Receive CLOV News and Ratings via Email

Sign-up to receive the latest news and ratings for Clover Health Investments and its competitors with MarketBeat's FREE daily newsletter.


Clover Health Investments logo

About Clover Health Investments

Clover Health Investments, Corp. operates as a Medicare Advantage insurer in the United States. The company through its software platform provides preferred provider organization and health maintenance organization health plans for Medicare-eligible consumers. Clover Health Investments, Corp. was founded in 2014 and is headquartered in Franklin, Tennessee.

Headlines

See More Headlines

Industry, Sector and Symbol

Industry
Hospital & medical service plans
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:CLOV
Fax
N/A
Employees
458
Year Founded
N/A

Sales & Book Value

Annual Sales
N/A
Book Value
$0.98 per share

Profitability

Net Income
$-6.74 million
Pretax Margin
-74.50%

Debt

Price-To-Earnings

Miscellaneous

Free Float
N/A
Market Cap
$1.81 billion
Optionable
Not Optionable

Company Calendar

Last Earnings
11/09/2021
Today
12/04/2021
Fiscal Year End
12/31/2021
Next Earnings (Estimated)
2/08/2022

MarketRank

Overall MarketRank

1.74 out of 5 stars

Medical Sector

894th out of 1,388 stocks

Hospital & Medical Service Plans Industry

12th out of 13 stocks

Analyst Opinion: 2.7Community Rank: 3.7Dividend Strength: 0.0Insider Behavior: 1.7Valuation: 0.6 5 -4 -3 -2 -1 -












Clover Health Investments (NASDAQ:CLOV) Frequently Asked Questions

Is Clover Health Investments a buy right now?

5 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Clover Health Investments in the last year. There are currently 3 sell ratings and 2 hold ratings for the stock. The consensus among Wall Street analysts is that investors should "sell" Clover Health Investments stock.
View analyst ratings for Clover Health Investments
or view top-rated stocks.

When is Clover Health Investments' next earnings date?

Clover Health Investments is scheduled to release its next quarterly earnings announcement on Tuesday, February 8th 2022.
View our earnings forecast for Clover Health Investments
.

How were Clover Health Investments' earnings last quarter?

Clover Health Investments, Corp. (NASDAQ:CLOV) announced its quarterly earnings data on Tuesday, November, 9th. The company reported ($0.08) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.31) by $0.23. The firm earned $427.16 million during the quarter, compared to analyst estimates of $418.01 million.
View Clover Health Investments' earnings history
.

What guidance has Clover Health Investments issued on next quarter's earnings?

Clover Health Investments updated its FY 2021 earnings guidance on Wednesday, September, 8th. The company provided earnings per share guidance of for the period. The company issued revenue guidance of $1.40 billion-$1.50 billion, compared to the consensus revenue estimate of $811.48 million.

What price target have analysts set for CLOV?

5 analysts have issued 1-year target prices for Clover Health Investments' stock. Their forecasts range from $7.00 to $10.00. On average, they expect Clover Health Investments' stock price to reach $9.00 in the next twelve months. This suggests a possible upside of 109.3% from the stock's current price.
View analysts' price targets for Clover Health Investments
or view top-rated stocks among Wall Street analysts.

Who are Clover Health Investments' key executives?

Clover Health Investments' management team includes the following people:
  • Mr. Vivek Garipalli, Co-Founder, CEO & Chairman of Directors (Age 42)
  • Mr. Andrew Toy, Co-Founder, Pres, CTO & Director (Age 42, Pay $427.19k)
  • Ms. Gia Lee Esq., Gen. Counsel & Sec. (Age 51, Pay $425.96k)
  • Mr. Joseph Wagner, Chief Financial Officer (Age 47)
  • Ms. Jamie L. Reynoso, Chief Operating Officer (Age 51)
  • Dr. Kumar Dharmarajan, Chief Scientific Officer (Age 41)
  • Mr. Derrick L. Nueman, Head of Investor Relations & Corp. strategy
  • Ms. Wendy Richey, Chief Compliance Officer
  • Ms. Rachel Fish, Chief People Officer
  • Dr. Sophia Chang M.D., M.P.H., Chief Clinical Informatics Officer (Age 60)

Who are some of Clover Health Investments' key competitors?

What is Clover Health Investments' stock symbol?

Clover Health Investments trades on the NASDAQ under the ticker symbol "CLOV."

Who are Clover Health Investments' major shareholders?

Clover Health Investments' stock is owned by many different institutional and retail investors. Top institutional shareholders include PNC Financial Services Group Inc. (1.61%), BlackRock Inc. (0.85%), Geode Capital Management LLC (0.44%), Morgan Stanley (0.41%), Citadel Advisors LLC (0.00%) and Jane Street Group LLC (0.00%).
View institutional ownership trends for Clover Health Investments
.

Which institutional investors are selling Clover Health Investments stock?

CLOV stock was sold by a variety of institutional investors in the last quarter, including Citadel Advisors LLC, Jane Street Group LLC, Picton Mahoney Asset Management, PEAK6 Investments LLC, IMC Chicago LLC, Sculptor Capital LP, SG Americas Securities LLC, and Citigroup Inc..
View insider buying and selling activity for Clover Health Investments
or view top insider-selling stocks.

Which institutional investors are buying Clover Health Investments stock?

CLOV stock was bought by a variety of institutional investors in the last quarter, including PNC Financial Services Group Inc., BlackRock Inc., Morgan Stanley, Geode Capital Management LLC, Sage Rhino Capital LLC, Goldman Sachs Group Inc., Summit Rock Advisors LP, and Balyasny Asset Management LLC.
View insider buying and selling activity for Clover Health Investments
or or view top insider-buying stocks.

How do I buy shares of Clover Health Investments?

Shares of CLOV can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Clover Health Investments' stock price today?

One share of CLOV stock can currently be purchased for approximately $4.30.

How much money does Clover Health Investments make?

Clover Health Investments has a market capitalization of $1.81 billion.

How many employees does Clover Health Investments have?

Clover Health Investments employs 458 workers across the globe.

What is Clover Health Investments' official website?

The official website for Clover Health Investments is www.cloverhealth.com.

Where are Clover Health Investments' headquarters?

Clover Health Investments is headquartered at 317 University Ave Suite 200, Palo Alto CA, 94301.

How can I contact Clover Health Investments?

Clover Health Investments' mailing address is 317 University Ave Suite 200, Palo Alto CA, 94301. The company can be reached via phone at 201-432-2133 or via email at [email protected].


This page was last updated on 12/4/2021 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.